It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
OBJECTIVES: Sexual dysfunction was reported to compromise the quality of life in childhood cancer survivors. The aim of
our study was to evaluate the reproductive health in long-term pediatric cancer survivors by conducting a crosscut survey.
MATERIAL AND METHODS: Childhood cancer survivors over 18 years of age, who were in remission for more than 5 years,
were invited to complete a gender-specific questionnaire surveying on their reproductive health. Demographic and treatment
data were retrieved from their medical records. Treatment modalities were reviewed for its potential gonadotoxicity.
RESULTS: 34 (17 males and 17 females, respectively) from 346 addressed survivors (9.8%) completed the questionnaire. Median
age and follow-up after diagnosis was 27 (18–35) and 14 (3–25) years, respectively. Some respondents reported sexual
concerns: 11.8% males experienced problems with penetration, two males (11.8%) who underwent semen analysis were
found to be azoospermic. Similarly, 11.8% females reported delayed puberty, the average age of menarche was 14 (12–17)
years, 29.4% females reported irregular menstrual cycles. Cyclophosphamide equivalent dose (CED) differed significantly
between the patients treated for leukemia, lymphoma and solid tumors (3000 vs 4352 vs 6660 mg/m2, respectively, p = 0.014).
CONCLUSIONS: Low prevalence of sexual dysfunction, fertility related disorders or delayed puberty in childhood cancer
survivors was found. However, the results should be interpreted with caution taking into account a low response rate.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Vilnius University, Faculty of Medicine, Lithuania
2 Center of Obstetrics and Gynecology, Vilnius University, Lithuania
3 Center for Pediatric Oncology and Hematology, Vilnius University, Lithuania
4 Vilnius University, Faculty of Medicine, Lithuania. [email protected]